18.02.2026
FimmCyte Announces Strategic Collaboration with Gedeon Richter in Endometriosis
FimmCyte AG, a pioneering Swiss biotech developing targeted immunotherapies for chronic fibro‑inflammatory … Sciences Fund), Innosuisse, BaseLaunch, University Hospital Zurich (USZ), Venture Kick, KickFund, and Gebert Rüf.
> zum Detail